Donor insulin use during stay in the intensive care unit should not preclude pancreas transplantation.

Pedro Ventura-Aguiar, Enrique Montagud-Marrahi, Antonio J Amor, Fritz Diekmann

Journal: Diabetologia 2022;64(9):2122-2123

PMID: 34052854

Abstract

Address: Nephrology and Kidney Transplant Department, Hospital Clínic Barcelona, Barcelona, Spain. [email protected].; Laboratori Experimental de Nefrologia I Trasplantament (LENIT), Fundació Clínic per a la Recerca Biomèdica (FCRB), Barcelona, Spain. [email protected].; Nephrology and Kidney Transplant Department, Hospital Clínic Barcelona, Barcelona, Spain.; Laboratori Experimental de Nefrologia I Trasplantament (LENIT), Fundació Clínic per a la Recerca Biomèdica (FCRB), Barcelona, Spain.; Diabetes Unit, Endocrinology and Nutrition Department, Hospital Clínic Barcelona, Barcelona, Spain.

DOI: 10.1007/s00125-021-05479-3

Link outs

Free resources

Medical:

https://medlineplus.gov/diabetesmedicines.html

Subscription / membership required

Full Text Sources:

https://doi.org/10.1007/s00125-021-05479-3

MeSH Terms: Graft Survival, Humans, Insulins, Intensive Care Units, Pancreas Transplantation, Tissue Donors